text
stringlengths 1
711
|
|---|
costs, we see SG&A as a lever to help drive operating growth in the years ahead as the
|
company 1) continues to exercise disciplined cost management with zero-based
|
budgeting practices; and 2) works to take out costs over time related to the ~$100M
|
incremental costs associated with the separation from JNJ, including exiting transition
|
services agreements, primarily over the next two years as well as transition
|
manufacturing agreements, which we estimate account for roughly 60% of the
|
incremental stand-alone costs. At the same time, we expect KVUE to further support its
|
brands through increased advertising spending in the near term following a period of
|
This document is being provided for the exclusive use of DAVID WANG at MARLOWE PARTNERS LP.
|
28
|
Andrea Teixeira, CFA AC
|
(1-212) 622-6735
|
andrea.f.teixeira@jpmorgan.com
|
North America Equity Research
|
29 May 2023 J P M O R G A N
|
being more selective in 2022.
|
Specifically, we are modeling for SG&A as a percent of sales to be 42 bps unfavorable
|
YOY in 2023, roughly neutral in 2024, and 51 bps favorable in 2025, which would then
|
put SG&A as a percent of sales just below 2022 levels. Within SG&A, advertising has
|
been a bit lumpy and oscillated between favorable and unfavorable to margins over the
|
past three years. Investments increased in 2021 to support top-line growth and key
|
brands but were lower in 2022 as the company made more discriminating decisions on
|
advertising given the supply disruptions and inflationary cost environment (balancing
|
investment with profitability). We see the company stepping up investments in 2023 to
|
support the top-line growth, primarily in the Self Care segment.
|
Figure 40: KVUE Operating Expense Outlook
|
33.2%
|
31.7%
|
33.6% 33.4% 33.9% 33.9% 33.3%
|
2.7%
|
2.2%
|
2.4% 2.5%
|
2.6% 2.6%
|
2.6%
|
-250
|
-200
|
-150
|
-100
|
-50
|
0
|
50
|
100
|
150
|
200
|
250
|
29%
|
30%
|
31%
|
32%
|
33%
|
34%
|
35%
|
36%
|
37%
|
2019 2020 2021 2022 2023E 2024E 2025E
|
SG&A % of Sales R&D % of Sales YOY Favorable/(Unfavorable) bps
|
Source: Company reports and J.P. Morgan estimates.
|
Figure 41: KVUE Advertising Expense
|
8.8%
|
8.5%
|
9.7%
|
9.1%
|
9.5%
|
9-10%
|
-150
|
-100
|
-50
|
0
|
50
|
100
|
7.5%
|
8.0%
|
8.5%
|
9.0%
|
9.5%
|
10.0%
|
10.5%
|
2019 2020 2021 2022 2023E Target
|
Advertising Expense % of Sales YOY Favorable/(Unfavorable) bps
|
Source: Company reports and J.P. Morgan estimates.
|
A&P Spend Is Up but Still Trails Most Peers, Yet...
|
KVUEs advertising spend of about 9.1% of sales is a bit below close HPC peers like
|
CL (11.1%) and PG (9.9%), although as we noted above we expect A&P spending to
|
step up 40 bps in 2023E to 9.5%. We note that some of the comparisons vs. peers are not
|
apples to apples as some companies account for go-to-market activities (e.g., sampling,
|
sales force, etc.) within advertising expense, which makes spend appear elevated. Also,
|
we note that marketing productivity has been up, which helps explain the relatively
|
higher efficient ratio (lower A&P as a percentage of sales). Historically, the company
|
had made efforts to improve SG&A efficiency through organization redesign (reduced
|
head count 10% from 2019-2022) and also increasing ROI on media spend by 28% from
|
2019-2021.
|
Figure 42: Advertising Expense vs. Peers
|
CY22 or Last Fiscal* where noted
|
0%
|
5%
|
10%
|
15%
|
20%
|
25%
|
30%
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.